已收盘 05-08 16:00:00 美东时间
+0.020
+0.08%
Poland - Factors to Watch May 4 WARSAW, May 4 (Reuters) - The following are significant news stories, press reports and events on Monday. ALL TIMES GMT (Poland: GMT + 2 hours): EU SUMMIT IN ARMENIA On Monday, Polish Prime Minister Donald Tusk will participate in the European Political Community summ
05-04 13:44
BRIEF-OpenAI In Talks To Commit Up To $1.5 Billion To Private-Equity Joint Venture-FT April 22 (Reuters) - OPENAI IN TALKS TO COMMIT UP TO $1.5BN TO PRIVATE-EQUITY JOINT VENTURE- FT Source text: https://tinyurl.com/bdc546ut Further company coverage: MSFT.O (( Reuters.Briefs@thomsonreuters.com ;))
04-22 12:09
Mobius Investment Trust Plc ( ($GB:MMIT) ) has shared an update. Mobius Investm...
03-20 23:47
BRIEF-Japan, U.S. To Agree On Joint Development Of Rare Earth Elements, Lithium, Copper At Summit Meeting This Week, Nikkei Says March 17 (Reuters) - Mitsubishi Materials Corp 5711.T : JAPAN, U.S. TO AGREE ON JOINT DEVELOPMENT OF RARE EARTH ELEMENTS, LITHIUM, COPPER AT SUMMIT MEETING THIS WEEK, NIKK
03-17 17:14
FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
03-17 00:42
BRIEF-Summit Royalties Announces Agreement to Acquire Royalty on Newmont's Saddle North Deposit March 12 (Reuters) - Summit Royalties Ltd SUM.V : SUMMIT ROYALTIES ANNOUNCES AGREEMENT TO ACQUIRE ROYALTY ON NEWMONT'S SADDLE NORTH DEPOSIT SUMMIT ROYALTIES LTD - TO BUY 1.0% NSR ROYALTY ON SADDLE NORTH F
03-12 18:25
Bezuclastinib mean TSS reduction deepens to –32.0 points at 48 weeks of treatment with further improvement shown across all measured symptoms99% of patients achieve >50% reduction in serum tryptase at 48 weeks, with
03-02 15:51
Mobius Investment Trust Plc ( ($GB:MMIT) ) has issued an update. Mobius Investm...
02-18 18:32
SL Green Realty Corp full-year 2025 net income attributable to shareholders at USD -111.86 million, down from prior year SL Green Realty Corporation reported a net loss attributable to common stockholders of USD 111.86 million for the full year 2025. Funds from Operations (FFO) attributable to commo
02-18 06:28
Cogent Biosciences Q4 net loss widens Overview Biotech firm reported Q4 2025 net loss of $102.5 mln, increased from last year Company maintains strong cash position with $901 mln, funding operations into 2028 Bezuclastinib NDA submissions on track for 2026, including AdvSM and GIST indications Outlo
02-17 21:07